JP2008540566A5 - - Google Patents

Download PDF

Info

Publication number
JP2008540566A5
JP2008540566A5 JP2008511394A JP2008511394A JP2008540566A5 JP 2008540566 A5 JP2008540566 A5 JP 2008540566A5 JP 2008511394 A JP2008511394 A JP 2008511394A JP 2008511394 A JP2008511394 A JP 2008511394A JP 2008540566 A5 JP2008540566 A5 JP 2008540566A5
Authority
JP
Japan
Prior art keywords
composition
cancer
administered
max
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008511394A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008540566A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/018404 external-priority patent/WO2006124573A2/en
Publication of JP2008540566A publication Critical patent/JP2008540566A/ja
Publication of JP2008540566A5 publication Critical patent/JP2008540566A5/ja
Withdrawn legal-status Critical Current

Links

JP2008511394A 2005-05-12 2006-05-12 2−デオキシグルコースを用いたがんの処置 Withdrawn JP2008540566A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68070805P 2005-05-12 2005-05-12
US78730406P 2006-03-29 2006-03-29
PCT/US2006/018404 WO2006124573A2 (en) 2005-05-12 2006-05-12 Treatment of cancer with 2-deoxyglucose

Publications (2)

Publication Number Publication Date
JP2008540566A JP2008540566A (ja) 2008-11-20
JP2008540566A5 true JP2008540566A5 (enExample) 2009-06-25

Family

ID=37431901

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008511394A Withdrawn JP2008540566A (ja) 2005-05-12 2006-05-12 2−デオキシグルコースを用いたがんの処置

Country Status (2)

Country Link
JP (1) JP2008540566A (enExample)
WO (1) WO2006124573A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0702446D0 (en) * 2007-02-08 2007-03-21 Sterix Ltd Composition
AU2008223541B2 (en) * 2007-03-02 2012-04-05 Amgen Inc. Methods and compositions for treating tumor diseases
WO2009143515A2 (en) * 2008-05-23 2009-11-26 University Of Miami Treatment using continuous low dose application of sugar analogs
PL2391363T3 (pl) * 2009-01-29 2017-03-31 Young Hee Ko Kompozycje i sposoby do leczenia raka
CN110831603A (zh) * 2017-06-28 2020-02-21 株式会社先端医疗开发 药物组合物以及肿瘤免疫活性促进剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670330B1 (en) * 2000-05-01 2003-12-30 Theodore J. Lampidis Cancer chemotherapy with 2-deoxy-D-glucose

Similar Documents

Publication Publication Date Title
JP2024015120A5 (enExample)
JP2002513762A5 (enExample)
JP2010525050A5 (enExample)
JP2006515883A5 (enExample)
JP2006504795A5 (enExample)
WO2004043389B1 (en) Methods of treating cancer and related methods
JP2010059183A5 (enExample)
WO2004037190A3 (en) Modified release compositions of milnacipran
NZ587202A (en) Methods for measuring a patient response upon administration of a drug and compositions thereof
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
JP2013516493A5 (enExample)
JP2006513184A5 (enExample)
WO2000041504A3 (en) Use of tertbutylhydroquinone for lowering blood cholesterol and/or blood triblycerides
CN114081886A (zh) 一种适用于耐药结核病治疗的药物组合物
WO2005089448A3 (en) Administration of cisplatin by inhalation
JP2001520994A5 (enExample)
WO2010071308A1 (ko) 암에 대한 방사선 치료 증진용 조성물
TWI341728B (en) Combinations comprising epothilones and anti-metabolites
JP2016501208A5 (enExample)
JP2009539916A5 (enExample)
FI4070800T3 (fi) Kladribiinikuuri multippeliskleroosin hoitoa varten
WO2007103427A3 (en) Medical use of bilirubin and its structural analogues
JP2006528190A5 (enExample)
EP1778209B8 (en) Methods and compositions for oral delivery of fts
JP2022512158A5 (enExample)